Legend Biotech (NASDAQ:LEGN) Third Quarter 2024 Results Key Financial Results Revenue: US$160.2m (up 67% from 3Q 2023). Net loss: US$125.3m (loss widened by 101% from 3Q 2023). US$0.68 loss per share...
Source LinkLegend Biotech (NASDAQ:LEGN) Third Quarter 2024 Results Key Financial Results Revenue: US$160.2m (up 67% from 3Q 2023). Net loss: US$125.3m (loss widened by 101% from 3Q 2023). US$0.68 loss per share...
Source Link
Comments